June 3 (Reuters) - Impression Healthcare Ltd IHL.AX :
* WILL DISCONTINUE SALE OF ORAL DEVICES BY 30 JUNE 2020
* EXPECTS CURRENT QUARTER OF REVENUE TO BE SIGNIFICANTLY HIGHER VERSUS CORRESPONDING PERIOD
* EXPECTS GICS CODE TO BE CHANGED TO PHARMACEUTICALS, BIOTECHNOLOGY AND LIFE SCIENCES
* SEEKING TO CHANGE NAME TO INCANNEX HEALTHCARE LTD AT UPCOMING SHAREHOLDER MEET